Detalles de la búsqueda
1.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728380
2.
Sequence not salvage.
Br J Haematol
; 204(5): 1590-1592, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563345
3.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577874
4.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Eur J Haematol
; 111(2): 181-190, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082839
5.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266607
6.
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
Br J Haematol
; 197(1): 82-96, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166376
7.
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 97(5): 562-573, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35132679
8.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
Eur J Haematol
; 106(5): 708-715, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580608
9.
Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development.
Handb Exp Pharmacol
; 265: 57-71, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367950
10.
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT.
Biol Blood Marrow Transplant
; 26(9): 1559-1566, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417491
11.
Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma.
Curr Opin Oncol
; 32(5): 418-426, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32740095
12.
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Haematologica
; 105(2): 297-316, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31753925
13.
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP.
Eur J Haematol
; 104(3): 181-189, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31737951
14.
Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 204(2): 715-718, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38014808
15.
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience.
Haematologica
; 108(6): 1676-1679, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546416
16.
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma.
Ann Hematol
; 97(5): 839-849, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29359239
17.
Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT.
Br J Haematol
; 198(1): 209-213, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482558
18.
Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.
Br J Haematol
; 198(4): 785-789, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658101
19.
Bortezomib for the treatment of multiple myeloma.
Cochrane Database Syst Rev
; 4: CD010816, 2016 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27096326
20.
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT).
Transplant Cell Ther
; 30(1): 93.e1-93.e12, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37783337